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Summary Statement:  
The timing of pubertal mammary gland development is determined by availability of the 
chemokine CCL7, balanced by the scavenging receptor ACKR2 and the macrophage receptor 
CCR1.  
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Abstract 
Macrophages are key regulators of developmental processes, including those involved in 
mammary gland development. We previously demonstrated that the atypical chemokine 
receptor, ACKR2, contributes to control of ductal epithelial branching in the developing 
mammary gland by regulating macrophage dynamics. ACKR2 is a chemokine-scavenging 
receptor, which mediates its effects through collaboration with inflammatory chemokine 
receptors (iCCRs). Here we reveal reciprocal regulation of branching morphogenesis in the 
mammary gland, whereby stromal ACKR2 modulates levels of the shared ligand CCL7 to 
control the movement of a key population of CCR1-expressing macrophages to the ductal 
epithelium. In addition, estrogen, which is essential for ductal elongation during puberty, 
upregulates CCR1 expression on macrophages. The age at which girls develop breasts is 
decreasing, which raises the risk of diseases including breast cancer. This study presents a 
previously unknown mechanism controlling the rate of mammary gland development during 
puberty and highlights potential therapeutic targets. 
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Introduction 
Breast development (thelarche) is the first visible sign of puberty in females, and typically 
occurs between the ages of 8 and 13 (Merke and Cutler  Jr, 1996). Globally, the age at 
pubertal onset is falling (de Muinck Keizer-Schrama and Mul, 2001). Early puberty is 
associated with an increased risk of disease in later life, including type II diabetes heart 
disease, and cancer (Day et al., 2015). Importantly, girls who develop breasts before the age 
of 10 are 20% more likely to develop breast cancer (Bodicoat et al., 2014). Therefore, 
understanding the molecular and cellular mechanisms underlying breast development is of 
key importance. 
The mammary gland develops through branching morphogenesis, giving rise to ductal 
epithelial networks. In the mouse this process begins at around 3 weeks (MM Richert, KL 
Schwertfeger, JW Ryder, 2000), when highly proliferative structures known as terminal end 
buds (TEBs) form at the end of epithelial ducts and drive network formation. Supporting this 
process is a stromal population containing fibroblasts, extracellular matrix (ECM), adipocytes 
and immune cells (Wiseman and Werb, 2002). Prominent amongst the stromal immune cells 
are macrophages which are found throughout the gland and surrounding TEBs. 
Macrophages have been implicated in numerous developmental processes (Wynn, Chawla 
and Pollard, 2013), and mammary gland development is severely impaired in macrophage-
deficient mice with altered TEB formation, ductal elongation during puberty and lobuloalveoli 
development in pregnancy (Pollard and Hennighausen, 1994; Gouon-Evans, Rothenberg 
and Pollard, 2000). Overall these studies indicate a key role for macrophages in the 
regulation of ductal branching in the developing mammary gland.  
 
Macrophages are recruited in a dynamic manner into the mammary gland throughout 
development (Coussens and Pollard, 2011). The molecular mechanisms regulating the intra-
gland movement of macrophages as they migrate to terminal end buds to mediate their 
developmental effects, are not currently understood and insights into these mechanisms will 
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enhance our overall understanding of how macrophages control mammary gland 
development. Chemokines which comprise a family of proteins characterised by a conserved 
cysteine motif, are important in vivo regulators of macrophage intra-tissue dynamics. The 
chemokine family is subdivided into CC, CXC, XC and CX3C sub-families according to the 
cysteine distribution, and chemokines act through G-protein coupled receptors to mediate 
leukocyte migration (Nibbs and Graham, 2013). Within tissues chemokine distribution, and 
gradients, can be regulated by members of the atypical chemokine receptor (ACKR) family, 
which are 7-transmembrane spanning receptors that lack classical signalling responses to 
ligands and which are typically stromally-expressed (Nibbs and Graham, 2013). Therefore, 
together, signalling chemokine receptors and ACKRs regulate intra-tissue chemokine 
function and coordinate leukocyte migration. 
 
We have a long-standing interest in one of the atypical chemokine receptors, ACKR2. 
ACKR2 scavenges and degrades inflammatory CC-chemokines thereby regulating their 
intra-tissue concentration and spatial distribution (Nibbs and Graham, 2013). Accordingly it is 
a key player in the resolution of the inflammatory response with implications for 
autoimmunity and cancer (Nibbs et al., 2007; Di Liberto et al., 2008; Shams et al., 2017). We 
previously demonstrated a role for ACKR2 in regulating branching morphogenesis in the 
developing lymphatic system via control of macrophage dynamics around developing 
vessels (Lee et al., 2014). More recently we have shown that ACKR2 also regulates 
branching morphogenesis in the mammary gland and ACKR2-/- mice display precocious 
mammary gland development. In essence, ACKR2 deficiency results in increased levels of 
monocyte and macrophage attracting chemokines in the developing mammary gland and 
this is associated with dysregulation of macrophage numbers and accelerated branching 
morphogenesis (Wilson et al., 2017). The chemokines scavenged by ACKR2 are ligands for 
the signalling chemokine receptors CCR1, CCR2, CCR3, CCR4 and CCR5 (Fig. 1) (Nibbs 
and Graham, 2013; Bachelerie et al., 2014). It is likely therefore that the effects of ACKR2 on 
mammary gland development are indirect, and a consequence of the regulation of levels of 
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chemokines capable of modulating macrophage function via one of these 5 receptors. 
Curiously, the dominant monocyte recruitment receptor, CCR2, does not control the rate of 
branching morphogenesis in the mammary gland (Wilson et al., 2017; Jäppinen et al., 2019), 
and mammary gland macrophages do not express CCR4 (Wilson et al., 2017). Together, 
this suggests that the phenotype seen in ACKR2-/- mammary glands is a consequence of 
altered responses through CCR1, CCR3 or CCR5. The purpose of this study was to 
determine which of these 3 receptors is the reciprocal partner of ACKR2, in the regulation of 
branching morphogenesis in the developing mammary gland. 
 
Here we identify CCR1, and its ligand CCL7, as key regulators working with ACKR2 in a 
reciprocal manner to regulate macrophage numbers, and branching morphogenesis, in the 
developing mammary gland. Collectively, this study sheds important light on the regulation of 
macrophage dynamics during virgin mammary gland development. 
 
Results 
Ductal branching in the pubertal mammary gland is regulated by CCR1. 
To determine involvement of CCR1, CCR3 and CCR5 in the regulation of ductal branching 
morphogenesis in the mammary gland we analysed carmine alum stained whole-mounts of 
mammary glands from 7 weeks old WT and CCR1-/-, CCR3-/- and CCR5-/- mice (Fig. 2A a-
c). The individual receptor deficient mice have different genetic backgrounds, therefore mice 
from each strain were compared to their specific WT (Douglas P Dyer et al., 2019). 
Quantitative analysis of the whole-mounts indicated that branched area, ductal elongation, 
TEB number and width were unaffected in CCR3-/- and CCR5-/- mice (Fig. 2A b-c, Fig. S1). 
In contrast, CCR1-/- mice exhibited delayed mammary gland development with decreased 
branched area at 7 and 8 weeks, reduced ductal elongation and decreased number and 
width of TEBs at 7 weeks (Fig. 2A a and Fig.2B a-d). In addition, in comparison to WT mice, 
CCR1-/- mice had thinner branches at 8 weeks (Fig. 2B e). This was not seen for CCR3-/- or 
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CCR5-/- mice (Fig. S1E). As observed for ACKR2-/- mice, by 12 weeks, when TEBs have 
regressed and ductal outgrowth is completed, branched area and ductal elongation are 
equivalent between WT and CCR1-/- mice (Fig. 2B a-b). Importantly the onset of puberty, as 
assessed by vaginal opening, was normal in CCR1-/- mice (Table S1). Together these data 
show that CCR1 regulates mammary gland development at a time point coincident with 
ACKR2 function in the same context.  
Of note, in contrast to ACKR2-/- mice, no difference was observed in the distance between, 
or density of, branches in WT and CCR1-/- mammary glands at any of the time points 
investigated (Fig. S2). This suggests that CCR1 does not regulate the density, but the 
spread of the ductal network.  
Importantly, previous publications have suggested potential redundancy in roles for CCR1, 3 
and 5 in vivo (Mantovani, 1999; Schall and Proudfoot, 2011). Whilst we have shown this not 
to be the case in acute inflammation (Douglas P Dyer et al., 2019), we have not examined 
potential receptor redundancy in the context of mammary gland development. Therefore, to 
test for any potential redundancy between the CCRs, mammary gland whole-mounts were 
obtained from iCCR-/- mice which have a compound deletion of CCR1, CCR2, CCR3 and 
CCR5 (Douglas P Dyer et al., 2019). As observed in the absence of CCR1, iCCR-/- mice 
display similar delayed development at 7 weeks as demonstrated by reduced TEB number 
(Fig. S1C). No additional combinatorial effects of the receptors were observed indicating that 
CCR1 is a non-redundant regulator of mammary gland development. 
 
CCR1 and ACKR2 are expressed surrounding epithelium in the mammary gland. 
We next examined the expression patterns of CCR1 and ACKR2 within the developing 
mammary gland during late puberty. We used flow cytometry to identify the cell type(s) 
expressing CCR1 within the mammary gland. As currently available antibodies to murine 
CCR1 are of limited quality we included cells from CCR1-/- mice as a control. This analysis 
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demonstrated that CCR1 is only detectable on macrophages (CD45+SiglecF-
CD11b+F4/80+) within the mammary gland (Fig. 3A) and further in situ hybridisation showed 
the CCR1+ cells to be intimately associated with the ductal epithelium (Fig. 3B). In contrast 
to macrophages, eosinophils (CD45+ SiglecF+) and stromal and epithelial (CD45-) cells did 
not express CCR1 (Fig. 3A). We next examined ACKR2 expression in the mammary gland. 
Previously, we showed that ACKR2 is expressed by stromal fibroblasts in the developing 
virgin mammary gland (Wilson et al., 2017). Here we have used in situ hybridisation to locate 
expression of ACKR2 to stromal cells in the vicinity of the ductal epithelium. Importantly no in 
situ hybridisation signals were seen in the stroma of CCR1-/- or ACKR2-/- mammary glands 
(Fig. 3B).  
These data therefore demonstrate that CCR1 and ACKR2 are expressed by distinct cell 
types surrounding TEBs in the developing mammary gland. 
 
Estrogen induces CCR1 expression on macrophages. 
We next examined regulation of CCR1 expression on mammary gland macrophages. 
Estrogen is essential for mammary gland development and ductal epithelial growth and 
proliferation (Russell C. Hovey, Josephine F. Trott, 2002). ELISA-based analysis of estradiol 
levels in the plasma of the developing mouse indicated that its production rises over the 
same time frame in which we observe altered ductal development in ACKR2-/- and CCR1-/- 
mammary glands (Fig. 4A). Notably, there was no difference in the levels of estradiol in WT 
and ACKR2-/- mice, suggesting that the accelerated branching in ACKR2-/- mice is not 
caused by increased levels of estrogen. To determine whether estrogen regulates CCR1 
expression on mammary gland macrophages we enzymatically digested mammary glands 
and exposed the cells to DMSO (vehicle control) or 17β-estradiol for 1h at 37°C. CCR1 
expression was analysed by flow cytometry and shown to increase on CD45+ 
CD11b+F4/80+ macrophages in response to 17β-estradiol (Fig. 4B). There was no 
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significant difference between the level of CCR1 expression on WT and ACKR2-/- 
macrophages after exposure, indicating that ACKR2 does not regulate this process.  
To determine whether this was a direct effect of estradiol on mammary gland macrophages, 
CD11b+F4/80+ cells were isolated by FACS. In the absence of other cell types, CCR1 
expression was increased following exposure to 17β-estradiol indicating that estrogen 
induction of CCR1 results from a direct effect on mammary gland macrophages (Fig. 4C). In 
addition, we showed that transcription of CCR1 mRNA by purified CD11b+F4/80+ cells is 
increased in response to estradiol, suggesting that CCR1 is being synthesised de novo (Fig. 
4D). 
Notably, upregulation of CCR1 on macrophages in response to estradiol is age dependent, 
as there is no difference in CCR1 expression in mice older than 8 weeks (Fig. 4E). In 
addition, 17β-estradiol has no effect on macrophages isolated from the male fat pad or the 
peritoneum of pubertal female mice (Fig. 4E-F). Taken together, this suggests that the effect 
of estrogen on CCR1 expression is restricted to pubertal mammary gland macrophages and 
limited to the key developmental time frame we have identified. 
Chemokine levels are altered in the absence of CCR1 and ACKR2.  
To identify the specific chemokines involved in regulating mammary gland development 
through CCR1 and ACKR2, multiplex protein analysis of mammary gland lysates was carried 
out. In keeping with our previous data we showed that, in the absence of scavenging by 
ACKR2, the chemokines CCL7, CCL11 and CCL12 accumulate in the mammary gland at 
6.5 weeks (Fig. 5A) (Wilson et al., 2017). The current analysis further revealed elevated 
levels of the ACKR2 ligands CCL3 and CCL22 in the ACKR2 -/- mammary gland at 7 weeks 
(Fig. 5A). Notably, other key ACKR2 ligands associated with monocyte and macrophage 
migration i.e. CCL2 and CCL5 are unchanged in the ACKR2-/- mammary gland (Fig. 5A). 
Importantly, there were no significant differences in the levels of these chemokines in lysates 
obtained from male WT and ACKR2-/- inguinal fat pads, indicating that the changes 
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observed in female lysates are specifically associated with the mammary gland (Fig. S3). In 
CCR1-/- mice, the levels of CCL7, CCL11 and CCL12 were unchanged, suggesting that 
ACKR2 is functional in these mice and able to scavenge chemokines normally. A number of 
chemokines including CCL19, CXCL1 and CXCL12 which are not ligands for either ACKR2 
or CCR1, are increased in ACKR2-/- mice and decreased in CCR1-/- mice (Fig. 5). It is likely 
that their altered levels reflect variation in the numbers of chemokine-expressing immune 
cells or the extent of epithelial cell branching within the mammary gland. Bioinformatic 
analysis of mammary epithelial cell single cell data reveals that CXCL1, CXCL10 and 
CXCL12 are produced by epithelial cells (Fig. S4 (Bach et al., 2017)). 
 
CCR1 and ACKR2 reciprocally regulate CD206+ macrophages within the mammary 
gland. 
Reciprocal regulation of leukocyte dynamics by CCR1 and ACKR2 in the developing 
mammary gland should be reflected in complimentary changes in levels of key cellular 
populations in CCR1-/- and ACKR2-/- mice. We detected no significant differences in the 
lymphocyte populations or in non-macrophage myeloid cell populations investigated. 
However, differences in a key macrophage population were identified. To investigate the 
effects of CCR1 deficiency on macrophage levels in the mammary gland, flow cytometry of 
enzymatically digested 6.5 week old WT and CCR1-/- glands was carried out. The gating 
strategy employed is described in Fig. S5. CCR1-/- mice displayed no significant differences 
in the bulk macrophage population (CD45+CD11b+F4/80+) (Fig. 6A a and 6B a). However, 
we detected a significant decrease in the percentage of a small population of macrophages 
expressing CD206 (mannose receptor) (CD45+SiglecF-F4/80+CD206+) in CCR1-/- mice 
(Fig. 6A b and 6B b). Analysis of ACKR2-/- mice revealed a complimentary phenotype to 
CCR1-/- mice in that they displayed an increase in the percentage of macrophages in the 
mammary gland population and specifically of the CD206+ macrophage subset (Fig. 6C). To 
determine whether CD206+ macrophages are recruited later in CCR1-/- mice, we carried out 
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flow cytometric analysis at the later time points of 7, 8 and 12 weeks (Fig S6). The number of 
CD206+ macrophages were not increased in CCR1-/- mice at any of the time points 
investigated.  
Finally, we examined the effects of estrogen on the CD206+ macrophage population. Our 
data show that CCR1 expression was also increased on the surface of CD206+ 
macrophages in response to both 17β-estradiol and the estrogen mimic Bisphenol A (BPA) 
(Fig. 6D). No effect of estrogen on CCR1 expression was observed in male macrophages 
(Fig. 6D). 
Thus, a key population of CD206+ macrophages are reciprocally regulated by ACKR2 and 
CCR1. Importantly, CD206+ mammary gland macrophages have previously been implicated 
in branching morphogenesis (Jäppinen et al., 2019) and we propose that ACKR2 and CCR1 
reciprocally control this population to coordinate branching morphogenesis in the pubertal 
mammary gland.  
 
CCL7 regulates CD206+ macrophages and branching morphogenesis. 
Of the chemokines detected within the mammary gland, CCL7 is of particular interest as it is 
shared between CCR1 and ACKR2 (Fig. 1), and is elevated in the pubertal mammary glands 
of ACKR2-/- mice (Fig. 5A d)(Wilson et al., 2017). In addition, qRT-PCR analysis also 
revealed that CCL7 is transcribed, by purified F4/80+ cells, at higher levels than other 
ACKR2 ligands (Fig. 7A a). We therefore investigated its expression and function in the 
mammary gland. Using flow cytometry, intracellular staining revealed that CCL7 is produced 
by immune cells, including SiglecF+ eosinophils, SiglecF- F4/80+ macrophages, and 
SiglecF-Ly6C+ monocytes (Fig. 7A b). For each cell type, a markedly higher percentage of 
cells obtained from the female mammary gland produced CCL7, than from male fat pad 
cells. Notably, around 60% of female SiglecF+ cells produced CCL7 compared with 10% of 
male cells (Fig. 7A b). The percentage of CCL7+ cells was unaffected in the absence of 
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ACKR2 (Fig. 7A b). CCL7 is also produced by CD45- epithelial cells: mature (EpCAM+ 
CD49f-) and progenitor luminal (EpCAM+ CD49f+), and basal (EpCAM - CD49f+) cells (Fig. 
7A c, Fig. S5B). Further, bioinformatic analysis confirmed that CCL7 is produced by 
epithelial cells, including basal, luminal and myoepithelial cells (Fig. S4) (Bach et al., 2017).  
Given the notable CCL7 expression in the mammary gland, we next directly tested its 
potential role in mammary gland development. PBS or 2 µg of CCL7 was administered 
subcutaneously at the site of the mammary fat pad at the key time point of 6 weeks. After 3 
days, mammary glands were harvested for cellular analysis by flow cytometry and carmine 
alum whole-mount analysis. CCL7 administration alone was sufficient to increase the 
percentage of CD206+ macrophages, and the area of branching within the mammary gland 
(Fig. 7B). These data confirm that elevated levels of CCL7, as observed in ACKR2-/- mice, 
leads to increased numbers of CD206+ macrophages in the mammary gland and 
accelerated branching. To determine the specificity of this interaction, we investigated the 
effect of other chemokines on branching and macrophage recruitment. CCL3 or CCL11 
administration did not increase branching or the number of CD206+ macrophages in the 
mammary gland (Fig. S7). Thus, the CCL7/CCR1/ACKR2 signalling axis appears to be 
specific.  
 
Overall these data demonstrate a role for CCL7, a ligand shared by CCR1 and ACKR2, in 
branching morphogenesis. Lending further support to this conclusion is the fact that  
bioinformatic interrogation of the precocious puberty (CTD Gene-Disease Associations) 
dataset, using Harmonizome (Rouillard et al., 2016), revealed that CCL7 and ACKR2 are 
both associated with precocious puberty in children, with standardized values of 1.25588 
(p=0.09) and 1.02634 (p=0.011) respectively. 
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Discussion 
The importance of macrophages in controlling developmental processes is well known 
(Wynn, Chawla and Pollard, 2013). The role of chemokines and their receptors, which 
provide molecular cues to guide and position macrophages during development, is an 
emerging area of research (Lee et al., 2014; Wilson et al., 2017). Previously, we revealed 
that the scavenging atypical chemokine receptor, ACKR2 controlled macrophages in the 
mammary gland through a CCR2-independent pathway (Wilson et al., 2017). Here we have 
revealed a previously unknown immunological mechanism whereby, ACKR2 and the 
inflammatory chemokine receptor CCR1, interact with their shared ligand CCL7 to 
coordinate the levels of CD206+ macrophages, and thus, the extent of branching 
morphogenesis in the pubertal mammary gland. Importantly, administration of CCL7 alone 
was able to increase the percentage of CD206+ macrophages within the mammary gland 
and drive accelerated branching morphogenesis. We propose that in CCR1-/- mice, although 
CCL7 levels are unaltered, macrophages are unable to sense and respond to the ligand 
without the cognate receptor, leading to delayed branching (Fig. 8). 
Previously, it was thought that all mammary gland macrophages, at rest, and in 
pathology, were derived from the bone marrow (Coussens and Pollard, 2011). In our 
previous study, we showed that branching was unaltered in the absence of CCR2, indicating 
that the macrophage population responsible for promoting branching morphogenesis was 
unlikely to be bone marrow derived (Wilson et al., 2017). Recently, a novel CD206+ 
macrophage population has been identified in the mammary gland, which is unaffected in 
the absence of CCR2, but reduced in plvap-/- mice, which have reduced numbers of foetal-
derived macrophages (Jäppinen et al., 2019). Branching is severely impaired in these mice 
suggesting that foetal-derived macrophages play a key role in promoting branching 
morphogenesis (Jäppinen et al., 2019). We believe that the macrophage population 
identified in our study may be derived from the same embryonic population (Jäppinen et al., 
2019). It is important to note that the effect of CCR1 deficiency on mammary gland 
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development is less pronounced than was observed for complete loss of macrophages 
(Gouon-Evans, Rothenberg and Pollard, 2000). This suggests that macrophages which do 
not express CCR1, 2, 3 or 5, such as those recruited through CX3CR1 may also be 
important in regulating branching. A recent study has identified a population of ductal 
macrophages which express CX3CR1 and have important roles in surveillance and tissue 
remodelling (Dawson et al., 2020). 
Eosinophils are known to be important in controlling mammary gland development as 
branching complexity is reduced in CCL11 deficient mice, which have decreased numbers of 
eosinophils (Gouon-Evans, Rothenberg and Pollard, 2000). Here we have shown that 
eosinophils are an important source of CCL7 for macrophages. CCR3-/- mice also have 
reduced numbers of eosinophils (Douglas P. Dyer et al., 2019). Here, we reveal that the 
extent of branching is unaffected in CCR3-/- mice suggesting that eosinophils do not directly 
control the extent of branching in the mammary gland.  
CCR1 is an inflammatory chemokine receptor which is expressed by immune cells, 
and has been shown to be important in a number of pathologies, including: sepsis, viral 
infections, cancer and autoimmune disease (Domachowske et al., 2000; Katschke Jr. et al., 
2001; Ness et al., 2004; Kitamura et al., 2015). To our knowledge, this is the first description 
of a key role for CCR1 in development. Of note, in the placenta, CCR1 has been shown to 
be expressed by human trophoblasts as they switch to an invasive phenotype (Sato et al., 
2003). ACKR2 is highly expressed by placental trophoblasts, preventing excess levels of 
inflammatory chemokines from entering the foetus, from the mother’s circulation, by a 
process of chemokine compartmentalisation (Teoh et al., 2014; Lee et al., 2019). As CCR1 
expression has also been described in placental development, there could be wider 
implications of the interaction described in this study.   
  In the mouse, sexual maturity occurs at around 6 weeks (Topper and Freeman, 
1980). Here we report a marked increase in plasma estradiol levels between 6.5 and 7 
weeks. This is the key time point in ACKR2/CCR1-dependent regulation of branching 
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morphogenesis. ACKR2 expression in the mammary gland specifically peaks at 6.5 weeks 
and branching begins to accelerate at this time point (Wilson et al., 2017). We show that 
17β-estradiol increases CCR1 expression on macrophages. However, this is restricted to 
pubertal mammary gland macrophages, as older female, male and peritoneal macrophages 
do not respond. In addition to 17β-estradiol, the estrogen mimic, Bisphenol A also increased 
CCR1 expression on CD206+ macrophages. This may be of concern as BPAs are widely 
found in the environment and could potentially alter the immune response, and the extent of 
branching in the mammary gland, in children during puberty. Previously CCR1 expression on 
T cells was shown to be regulated by 17β-estradiol (Mo et al., 2005). However, this is the 
first description of estrogen controlled CCR1 expression on macrophages. This observation 
could have implications for our understanding of diseases where females exhibit increased 
susceptibility. One example is rheumatoid arthritis, where CCR1 is also associated with 
pathology (Katschke Jr. et al., 2001; van Vollenhoven, 2009). 
Understanding the molecular signals which guide the rate of branching 
morphogenesis in the mammary gland is highly important. Precocious puberty is a condition 
where puberty begins before the age of 8, with some girls developing breasts as early as 4. 
This results from early activation of the gonadotropic axis, leading to accelerated growth and 
bone maturation, but ultimately reduced stature (Carel et al., 2004). Potential risk factors 
include exposure to endocrine disrupters, obesity, stress and ethnicity (Cesario and Hughes, 
2007; Lee et al., 2007; Meeker, 2012; Kelly et al., 2017). As mammary gland development is 
delayed in mice in the absence of CCR1, this could represent a novel therapeutic target to 
treat aspects of precocious puberty. Several CCR1 antagonists are available and have been 
used in a number of clinical trials (Lebre et al., 2011). In addition, early breast development 
leads to higher risks of breast cancer in later life (Bodicoat et al., 2014), and women with 
dense breasts are more likely to develop breast cancer (Nazari and Mukherjee, 2018). This 
can be related to poor detection by mammography as the branches mask the cancer, but 
may also be caused by genetic factors, parity and alterations in the breast stroma. Both 
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ACKR2 and CCR1 have been shown to be important in the progression of breast cancer, 
therefore understanding early interactions between these receptors could reveal key 
insights, which drive later pathology (Kitamura et al., 2015; Shin et al., 2017; Hansell et al., 
2018). 
In this study, we have uncovered a novel mechanism by which estradiol upregulates CCR1 
expression by pubertal mammary gland macrophages and stromal ACKR2 modulates levels 
of CCL7, to control the movement of the CCR1+ macrophages to the ductal epithelium.  
Overall therefore our data demonstrate that CCR1 and ACKR2 coordinately regulate 
mammary gland branching morphogenesis. 
 
Methods 
Animals 
Animal experiments were carried out under the auspices of a UK Home Office Project 
Licence and conformed to the animal care and welfare protocols approved by the University 
of Glasgow. C57BL/6 mice, ACKR2-/- (Jamieson et al., 2005), CCR1-/-, CCR3-/-, CCR5-/- 
and iCCR-/- (Douglas P Dyer et al., 2019) mice were bred at the specific pathogen-free 
facility of the Beatson Institute for Cancer Research. 
Carmine Alum Whole Mount  
Carmine alum whole mounts were carried out as described previously (Wilson et al., 2017). 
Briefly, fourth inguinal mammary glands were fixed overnight in 10% neutral buffered 
formalin (NBF) (Leica) at 4°C. Glands were dehydrated for 1 h in distilled water, followed by 
70% ethanol and 100% ethanol before overnight incubation in xylene (VWR international). 
Tissue was rehydrated by 1 h incubation in 100% ethanol, 70% ethanol and distilled water, 
before staining in Carmine Alum solution overnight at room temperature (0.2% (w/v) carmine 
and 10 mM aluminium potassium sulphate (Sigma)). Tissue was dehydrated again before 
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overnight incubation in xylene. Finally, glands were mounted with DPX (Leica) and stitched 
bright-field images at 10× magnification were taken using an EVOS FL auto2 microscope 
(Thermofisher). Ductal elongation, and branched area from the lymph node, were measured 
using ImageJ 1.52a (Schneider, Rasband and Eliceiri, 2012). 5 x brightfield images were 
obtained using the Zeiss Axioimager M2 with Zen 2012 software. The numbers of branches 
and branch thickness were counted as the average from 3 measurements from 6 individual 
fields of view (F.O.V.) from each whole mount. TEBs were counted as the average from at 
least 2 F.O.V. from each whole mount. All samples were blinded before measurements were 
taken.  
RNAscope ® In situ hybridisation 
Mammary glands were fixed in 10% neutral buffered formalin at room temperature for 24-36 
hours before being dehydrated using rising concentrations of ethanol and xylene, and 
paraffin embedded (Shandon citadel 1000 (Thermo Shandon). Tissue was sectioned onto 
Superfrost plus slides (VWR) at 6 μm using a Microtome (Shandon Finesse 325 Microtome, 
Thermo). Slides were baked at 60oC for 1 h before pre-treatment. Slides were deparaffinised 
with xylene (5 mins x 2) and dehydrated with ethanol (1 min x 2). Tissues were incubated 
with Hydrogen peroxide for 10 mins at RT, then boiled in antigen retrieval buffer for 15 mins. 
Slides were treated with protease plus for 30 mins at 40oC. Slides were then hybridised 
using the RNAScope® 2.5 Red Manual Assay (Advanced cell diagnostics) according to the 
manufacturer’s instructions using the Mm-Ccr1 and Mm-ACKR2 probes. Slides were 
mounted in DPX (Sigma Aldrich) and imaged on an EVOS FL Auto2microscope. 
Mammary gland digestion  
The inguinal lymph node was removed from the fourth inguinal mammary gland, tissue was 
chopped, and enzymatic digestion was carried out in a 37°C shaking incubator at 200 rpm 
for 1 h, with 3 mg/ml collagenase type 1 (Sigma) and 1.5 mg/ml trypsin (Sigma) in 2 ml 
Leibovitz L-15 medium (Sigma). The suspension was shaken for 10 s before addition of 5 ml 
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of L-15 medium supplemented with 10% foetal calf serum (Invitrogen) and centrifugation at 
400 g for 5 min. Red blood cells were lysed using Red Blood Cell Lysing Buffer Hybri-Max 
(Sigma) for 1 min and washed in PBS. Cells were washed in PBS with 5 mM EDTA, 
resuspended in 2 ml 0.25% Trypsin-EDTA (Sigma) and incubated at 37°C for 2 min before 
addition of 5 ml of serum-free L-15 containing 1 μg/ml DNase1 (Sigma) for 5 min at 37°C. L-
15 containing 10% FCS was added to stop the reaction and cells were filtered through a 40 
μm cell strainer before a final wash in FACS buffer (PBS containing 1% FCS and 5 mM 
EDTA). 
Flow cytometry 
Antibodies were obtained from BioLegend and used at a dilution of 1:200: CD45 (30-F11), 
CD11b (M1/70), F4/80 (BM8), SiglecF (S17007L), Ly6C (HK1.4), EpCAM (G8.8), 
CD49f(GoH3), CCR1 (S10450E), and CD206 (C068C2) for 30 min at 4°C. Dead cells were 
excluded using Fixable Viability Dye eFluor 506 (Thermo Fisher). Intracellular staining for 
CCL7 was carried out using 1 in 100 biotinylated CCL7 antibody (R&D Systems) and 
Strepdavidin BV605 (BioLegend) and eBioscience intracellular fixation and permeabilization 
buffer. Flow cytometry was performed using an LSRII or Fortessa, (BDBiosciences) and 
analysed using FlowJo V10. FACS sorting was carried out using a BD FACS ARIA III. 
Proteomic analysis 
The inguinal lymph node was removed from the fourth inguinal mammary gland, tissue was 
chopped, frozen in liquid nitrogen, crushed with a mortar and pestle, and resuspended in 
dH2O containing protease inhibitors (Pierce). Protein levels were determined using a custom 
designed Magnetic Luminex Multiplex assay (R&D Systems), as described in the 
manufacturer’s instructions, and read with a Bio-Rad Luminex-100 machine. Data was 
normalised to the protein concentration of tissue samples, determined by a BCA assay 
(Pierce). 
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Subcutaneous administration of Chemokines  
2 µg of CCL7, CCL3 or CCL11 in 200 µl PBS (R&D Systems) was injected subcutaneously 
into mice at 6 weeks of age. After 3 days, mice were culled and mammary glands were 
excised and processed for whole mount and cellular analysis.    
17β-estradiol assays 
Fourth inguinal mammary glands were digested to obtain single cell suspensions. Cells were 
plated at 0.5-1 x 105 cells in a 96 well plate in L-15 media containing 5% FCS and exposed 
to DMSO (vehicle control) or 50 ug/ml 17-β estradiol or Bis-phenol A (Sigma) for 1 h at 37°C, 
5% CO2. Where CD11b+ F4/80+ cells were FACS sorted, 1 x 104 sorted cells per well were 
exposed to DMSO or Estradiol. The level of 17-β estradiol in plasma samples was 
determined using the Estradiol parameter kit (R&D Systems) as described in the 
manufacturer’s instructions. 
Transcriptional analysis 
Cells were lysed using Buffer RLT and processed using a microRNeasy kit (Qiagen) as 
described previously (Wilson et al., 2017). Transcription levels were determined by 
quantitative real-time polymerase chain reaction (qRT-PCR) using primers to detect CCR1 
and GAPDH (Douglas P. Dyer et al., 2019). Fold regulation was determined using the 2(−ΔCT) 
method, where ΔCT is calculated as CT target−CT normaliser. Normalisation was carried out using 
GAPDH. ACKR2 ligands were detected using the mouse Chemokine and Chemokine 
Receptor RT2 profiler PCR array (Qiagen) as described previously (Wilson et al., 2017).   
Bioinformatic analysis 
Chemokine expression by epithelial cells was determined by searching the data repository 
from Bach et al, 2017 (Bach et al., 2017) at: 
https://marionilab.cruk.cam.ac.uk/mammaryGland/.  
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Statistical analysis 
Data were analysed using GraphPad Prism 8.1.2. Normality was assessed using Shapiro 
Wilk and Kolmogorov–Smirnov tests. For data with normal distribution, two-tailed, unpaired t-
tests were used. Where data was not normally distributed, Mann–Whitney tests were used. 
Significance was defined as p<0.05 *. Error bars indicate standard error of the mean 
(S.E.M.). 
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Figures  
 
 
Figure 1: ACKR2 shares ligands with inflammatory chemokine receptors. Coloured 
lines indicate receptor ligand interactions. Data compiled from Bachelerie, F. et al., 2014 and 
Nibbs, R. J. B. & Graham, G. J., 2013. 
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Figure 2: Ductal branching in the pubertal mammary gland is regulated by CCR1. (A) 
Representative carmine alum whole mount images of late pubertal (7 week old) virgin 
mammary glands from a) wild-type and CCR1-/-, b) wild-type and CCR3-/- and c) wild-type 
and CCR5-/- mice. (B) Branching morphogenesis was quantified in 7 (WT n=4, CCR1-/- n= 
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5), 8 (WT n=10, CCR1-/- n= 7) and 12 (WT n=4, CCR1-/- n= 7) week mammary glands using 
ImageJ, by measuring: a) the area of branching from the inguinal lymph node, 7 week, two-
tailed t-test (p=0.0007) and 8 week, Mann-Whitney test (p=0.0312). b) ductal elongation, 
measured from the middle of the inguinal lymph node to the furthest edge of ductal 
outgrowth. 7 week, two-tailed t-test (p=0.026). c) The number of TEBs, was determined as 
the average number from at least 2 individual fields of view (FOV) (5×) per gland. 7 week, 
two-tailed t-test (p=0.0093) d) The average width of all TEBs was determined from at least 2 
F.O.V (5x) per gland. 7 week, two-tailed t-test (p=0.0201). e) Branch thickness was 
determined as the average of 6 measurements from 3 F.O.V (5x) per gland. 8 week, two-
tailed t-test (p=0.0015). Significantly different results are indicated. Scale bars denote 5 mm 
and error bars represent S.E.M. 
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Figure 3: CCR1 and ACKR2 are expressed surrounding epithelium in the mammary 
gland. (A) Flow cytometry analysis of CCR1 expression by enzymatically digested WT 
(black bars, n=6) and CCR1-/- (white bars, n=4) mammary gland cells: CD45+ SiglecF+, 
CD45+SiglecF-CD11b+F480+ and CD45-. (B) RNAscope® in situ hybridization of CCR1 
(highlighted by black arrow) and ACKR2 (highlighted by red arrow), in the developing virgin 
mammary gland of WT, CCR1-/- and ACKR2-/- mice. Significantly different results are 
indicated: two-tailed t-test, p=0.0305. Error bars represent S.E.M. 
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Figure 4: Estrogen induces CCR1 expression on macrophages. (A) Estradiol levels in 
plasma from 5.5 weeks WT (n=5), 6.5 weeks WT (n=5), 7 weeks WT (n=5), and 6.5 weeks 
ACKR2-/- (n=4). Two-tailed t-test (p=0.0064) (B) CCR1 expression by CD11b+F4/80+ cells 
in response to DMSO and 50 µg/ml estradiol in WT (n=5), ACKR2-/- (n=3) and CCR1-/- 
(n=4). WT, two-tailed t-test (p=0.004), ACKR2-/-, two-tailed t-test (p=0.0194). (C) unsorted 
(n=3) and CD11b+F4/80+ FACS sorted cells (n=2) from the mammary gland. Two-tailed t-
test (p=0.0217). (D) Transcription of CCR1 by CD11b+F4/80+ FACS sorted cells from WT 
(n=4) and CCR1-/- mice (n=2), in response to DMSO or Estradiol. Two-tailed t-test 
(p=0.0494).  (E) CCR1 expression by CD11b+F4/80+ cells from female WT mammary 
glands at 4, 8, 10 weeks old, female 7 week old CCR1-/- mice and male WT inguinal fat 
pads from 7 week old mice, in response to DMSO and 50 µg/ml 17β-estradiol (each group, 
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n=3). Two-tailed t-test (p=0.04). (F) CCR1 expression by CD11b+F4/80+ cells from the 
peritoneum, WT (n=5), ACKR2-/- (n=3) and CCR1-/- (n=4).  Significantly different results are 
indicated. Error bars represent S.E.M. 
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Figure 5: Chemokine levels are altered in the absence of ACKR2 and CCR1. Multiplex 
measurement of protein concentration of (A) inflammatory CC-chemokines in whole 
mammary gland homogenates; a) CCL2, b) CCL3, two-tailed t-test, ACKR2-/- (p=0.0183), 
CCR1-/- (p=0.0082). c) CCL5, two-tailed t-test, CCR1-/- (p=0.0235). d) CCL7, two-tailed t-
test, ACKR2-/- (p=0.024). e) CCL11, two-tailed t-test, ACKR2-/- (p=0.0014).  f) CCL12, two-
tailed t-test, ACKR2-/- (p=0.0279). g) CCL19, two-tailed t-test, ACKR2-/- (p=0.0216), CCR1-
/- (p=0.0065). h) CCL22, two-tailed t-test, ACKR2-/- (p=0.0108), CCR1-/- (p=0.0184). (B) 
CXC chemokines; a) CXCL1, two-tailed t-test, ACKR2-/- (p=0.0437), CCR1-/- (p=0.0023). b) 
CXCL10, two-tailed t-test, ACKR2-/- (p=0.0020). c) CXCL12, Mann-Whitney test, ACKR2-/- 
(p=0.0095), two-tailed t-test, CCR1-/- (p=0.0086). WT (CCR1) n=11, CCR1-/- n=11, WT 
(ACKR2) n=6, and ACKR2-/- n=4. Significantly different results are indicated. Error bars 
represent S.E.M.  
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Figure 6: CCR1 and ACKR2 reciprocally regulate CD206+ macrophages within the 
mammary gland. (A) Flow cytometry was used to reveal a) CD11b+F4/80+ and b) SiglecF- 
F4/80+ CD206+ macrophages, within the CD45+ compartment of the 6.5 weeks old 
developing mammary gland. Flow cytometry of (B) WT (n=6) and CCR1-/- (n=9) mammary 
glands to reveal the determine the percentage of a) CD11b+F4/80+ cells, and b) SiglecF- 
F4/80+ CD206+ cells, two-tailed t-test (p=0.0079). Flow cytometry of (C) WT (n=8) and 
ACKR2-/- (n=5) mammary gland cells was carried out for a) CD11b+F4/80+ cells, two-tailed 
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t-test (p=0.0339), and b) SiglecF- F4/80+ CD206+ cells, two-tailed t-test (p=0.0439). (D) 
CCR1 expression by SiglecF- F4/80+ CD206+ cells in response to DMSO and 50 µg/ml 17β-
estradiol and Bisphenol A; female WT and CCR1-/- and male WT (each group, n=3). Two-
tailed t-test, estradiol (p=0.0381) and BPA (p=0.0307). Significantly different results are 
indicated. Error bars represent S.E.M. 
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Figure 7: CCL7 controls CD206+ macrophages and branching morphogenesis. (A) a) 
Transcription of inflammatory chemokines by purified F4/80+ cells (n=3). CCL7 is produced 
in the mammary gland by b) immune cells; including SiglecF+, SiglecF-F4/80+ and SiglecF-
Ly6C+, female WT (n=6) female ACKR2-/- (n=4) and male WT (n=7). Two-tailed t-test, 
SiglecF+ (p=0.0012), SiglecF-F4/80+ (p=<0.0001) and Mann-Whitney, SiglecF-Ly6C+ 
(p=0.0198). c) CCL7 production by epithelial cells, Mature Luminal (EpCAM+ CD49f-), 
progenitor luminal (EpCAM+ CD49f+), and basal (EpCAM- CD49f+), female WT (n=6) and 
ACKR2-/- (n=4). (B) 3 days after subcutaneous administration of PBS or 2 µg CCL7 at 6 
weeks, a) the percentage of SiglecF-F4/80+CD206+ cells was measured by flow cytometry. 
(PBS, n=11, CCL7, n=13), Mann-Whitney test (p=0.0289) and b) the area of branching was 
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measured using Image J (PBS, n=10, CCL7, n=7), Mann-Whitney test (p=0.0185). c) and d) 
Representative images of whole mounts from PBS and CCL7 injected mice. Significantly 
different results are indicated. Error bars represent S.E.M.  
  
D
ev
el
o
pm
en
t •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
  
Figure 8: Proposed mechanism by which chemokine receptors CCR1 and ACKR2 
coordinate mammary gland development. Estrogen increases CCR1 expression on 
macrophages (purple) during puberty, and stromal fibroblast (green) expressed ACKR2 
modulates levels of CCL7 (grey circles) to control the movement of CCR1+ macrophages to 
the ductal epithelium (orange). Schematic image was created with BioRender. 
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Figure S1: CCR3 and CCR5 do not control the extent of branching 
morphogenesis. Branching morphogenesis in carmine alum whole mounts were quantified in 7 
weeks old mammary glands; (WT (CCR3) n=6, CCR3-/- n= 5; WT (CCR5) n=4, CCR5-/- n= 4). (A) 
the area of branching from the inguinal lymph node, (B) ductal elongation, 
measured from the middle of the inguinal lymph node to the furthest edge of ductal 
outgrowth. (C) The number of TEBs, was determined as the average number from at least 2 
individual fields of view (FOV) (5×) per gland. WT (iCCR) n=3, iCCR-/- n= 3), two-tailed t-test 
(p=0.0014). (D) The average width of all TEBs was determined from at least 2 F.O.V (5x) per 
gland. (E) Branch thickness was determined as the average of 3 measurements from 6 x F.O.V 
(5x) per gland. Error bars represent S.E.M. 
Development: doi:10.1242/dev.187815: Supplementary information
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Figure S2: Branch density is unaffected in CCR1-/- mice. Branching 
morphogenesis in carmine alum whole mounts were quantified in 7 (WT n=4, CCR1-/- n= 5), 8 
(WT n=10, CCR1-/- n= 7) and 12 (WT n=4, CCR1-/- n= 7) week mammary glands; in terms of (A) 
the distance between branches, and (B) the number of branches in a 5 x F.O.V. Each data point 
represents the average of 3 measurements from 6 individual F.O.V. per gland. Error bars 
represent S.E.M. 
Development: doi:10.1242/dev.187815: Supplementary information
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Figure S3: Chemokine levels in the male fat pad are unaffected in the absence of ACKR2. 
Multiplex measurement of protein concentration of (A) CCL2, (B) 
CCL3, (C) CCL5, (D) CCL7, (E) CCL11, (F) CCL12, (G) CCL19, (H) CCL22, (I) CXCL1, (J) 
CXCL10 and (K) CXCL12 in whole fat fad homogenates. WT n=6, and ACKR2-/- n=6. Error bars 
represent S.E.M.  
Development: doi:10.1242/dev.187815: Supplementary information
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Development: doi:10.1242/dev.187815: Supplementary information
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Figure S4: Chemokines are produced by epithelial cell subsets. 
Expression of (A) CXCL1, (B) CXCL10, (C) CXCL10 and (D) CCL7 by epithelial cells was 
determined by searching the single cell RNAseq data repository from Bach et al, 2017 (Bach et 
al., 2017) at: https://marionilab.cruk.cam.ac.uk/mammaryGland/. Epithelial subsets 
include; hormone sensing differentiated (Hsd), differentiated alveolar (Avd), hormone 
sensing progenitor (Hsp), luminal progenitor (Lp), basal (Bsl), myoepithelium (Myo), Procr+ (Prc). 
Development: doi:10.1242/dev.187815: Supplementary information
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Figure S5: Gating strategy to define immune and epithelial cells in the mammary gland. 
Flow cytometry was carried out to measure the percentage of cells in the mammary gland. 
Initially, single cells were gated, dead cells were excluded, and CD45+ 
immune cells were gated. Populations were then expressed as a percentage of CD45+ cells, 
including; (A) a) CD11b+F4/80+, and b) SiglecF-F4/80+CD206+ cells. (B) For epithelial cell 
subsets, live, single CD45- cells were gated. Populations were then expressed as a 
percentage of CD45- cells, including mature (EpCAM+ CD49f-) and progenitor luminal 
(EpCAM+ CD49f+), and basal (EpCAM - CD49f+) cells. 
Development: doi:10.1242/dev.187815: Supplementary information
D
ev
el
o
pm
en
t •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
Figure S6: CD206+ macrophages throughout development. Flow 
cytometry was used to determine the number of SiglecF- F4/80+ CD206+ macrophages, within 7 
(each group, n=6), 8 and 12 (WT, n=4 CCR1-/-, n=5) weeks old developing 
mammary glands. Significantly different results are indicated. Mann-Whitney test, p=0.0152. 
Error bars represent S.E.M. 
Development: doi:10.1242/dev.187815: Supplementary information
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Figure S7: CCL3 and CCL11 do not control CD206+ macrophages or the 
extent of branching morphogenesis. 3 days after subcutaneous administration of PBS, 2 µg 
CCL3 or CCL11 at 6 weeks, (A) the percentage of SiglecF-F4/80+CD206+ cells 
measured by flow cytometry. (PBS, n=8, CCL11, n=8, CCL3, n=9) and (B) the area of 
branching was measured using Image J (each group, n=5).  
Table S1: Pubertal onset in CCR1-/- mice 
Day* 38 42 45 
WT 9/11 (81.8%) 11/11 (100%) 11/11 (100%) 
CCR1-/- 5/8 (62.5%) 7/8 (87.5%) 8/8 (100%) 
*Pubertal onset determined by assessing vaginal opening. 
Development: doi:10.1242/dev.187815: Supplementary information
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